OverviewChartNewsTraderScreen

BVT Put 250 BIIB 20.09.2024/  DE000VM36AA0  /

Frankfurt Zert./VONT
14/06/2024  10:31:19 Chg.+0.100 Bid12:16:54 Ask12:16:54 Underlying Strike price Expiration date Option type
2.300EUR +4.55% 2.280
Bid Size: 12,000		 2.390
Ask Size: 12,000		 Biogen Inc 250.00 USD 20/09/2024 Put
GlobeNewswire 03:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire 13/06 Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Inve...
GlobeNewswire 13/06 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire 13/06 DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire 13/06 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire 13/06 BIOGEN LEGAL DEADLINE: If You Lost Money on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Enco...
GlobeNewswire 13/06 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 12/06 BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire 11/06 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 11/06 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire 11/06 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 11/06 BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminde...
TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 10/06 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire 10/06 Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to C...
GlobeNewswire 10/06 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire 10/06 FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire 08/06 BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal ...
GlobeNewswire 07/06 BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc...
GlobeNewswire 07/06 Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) S...
GlobeNewswire 07/06 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire 06/06 Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join – Contact The Gross L...
GlobeNewswire 06/06 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...